Lamotrigine Tablet, Chewable
Product Images NDC 55111-225

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 55111-225). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr.reddy's Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1 (Carton1)

Lamotrigine 5 mg chewable, dispersible tablets carton from Dr. Reddy's Laboratories Limited. The label shows the product name, strength, dosage form, and cautions for pharmacists to verify the product dispensed. It includes storage instructions and packaging details indicating 100 tablets in 10 blister cards. Manufactured by Dr. Reddy's Laboratories Limited in India.*

FDA Label Image

Carton2 (Carton2)

Lamotrigine 25 mg chewable, dispersible tablets packaging label from Dr. Reddy's Laboratories Limited. The label indicates 100 tablets (10 x 10 unit-dose blister cards) with dosage instructions and storage conditions. It includes warnings to verify product dispensed and pharmacy guidelines to provide the accompanying medication guide to patients.*

FDA Label Image

Container1 (Container1)

Lamotrigine 5 mg chewable, dispersible tablets carton label showing 100 tablets, produced by Dr. Reddy's Laboratories Limited. The label includes caution note to verify product dispensed and pharmacist instructions to dispense medication guide. It lists dosage form as chewable tablets and specifies storage and dosage information.*

FDA Label Image

Container2 (Container2)

Lamotrigine 25 mg chewable, dispersible tablets in a carton label from Dr. Reddy's Laboratories Limited. The label includes dosage strength, dosage form, a caution to verify product dispensed, directions for pharmacists to dispense accompanying medication guide, and storage instructions. The package contains 100 tablets for oral use.*

FDA Label Image

Fig1

A Kaplan-Meier failure probability curve comparing Lamotrigine and a placebo over approximately 90 weeks. The graph shows failure probability on the y-axis and weeks on the x-axis, with censored data points marked, illustrating the difference in failure probability between Lamotrigine and placebo groups over time.*

FDA Label Image

Fig2

A Kaplan-Meier failure probability curve comparing Lamotrigine and placebo over approximately 80 weeks. The y-axis represents failure probability (%) and the x-axis shows time in weeks. The graph illustrates the difference in failure probability between Lamotrigine and placebo groups across the study duration.*

FDA Label Image

Structure (Structure)

Chemical structure of lamotrigine, showing a triazine ring with chlorine and amine substitutions, as depicted in the molecular diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.